SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (230)6/15/2001 3:55:37 PM
From: Mike McFarland  Respond to of 319
 
arktherapeutics.com

4th April 2001 Ark Therapeutics EG009 Gene Therapy Doubles Survival Time For Malignant Glioma Patients

26th January 2001 Eurogene Acquires Oy Quattrogene, Merged International Operation To Be Called Ark Therapeutics

28th November 2000 Eurogene Granted Orphan Drug Status For Trinamâ„¢ By The FDA

5th September 2000 Scientists Develop Potential Novel System For Human Gene Therapy

6th May 2000 Eurogene Limited Raises £15 Million in European Financing

6th May 2000 Eurogene Limited New Board and Executive Management Team Announced

23rd March 2000 Eurogene And Valentis Inc. Initiate Clinical Trial For The Prevention Of Blood Vessel Hyperplasia